amifostine anhydrous has been researched along with Bile Duct Cancer in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, M | 1 |
| Smith, DE | 1 |
| Normolle, DP | 1 |
| Knol, JA | 1 |
| Pan, CC | 1 |
| Ben-Josef, E | 1 |
| Lu, Z | 1 |
| Feng, MR | 1 |
| Chen, J | 1 |
| Ensminger, W | 1 |
| Lawrence, TS | 1 |
1 trial available for amifostine anhydrous and Bile Duct Cancer
| Article | Year |
|---|---|
A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy.
Topics: Adult; Aged; Amifostine; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; C | 2012 |